Antimitotic Agents: all 5,052 studies that test it

Page 13 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.

• Compassionate Use of Eribulin for the Treatment of Advanced Breast Cancer Refractory to All Other Marketed TherapiesCompletedNCT01142661Not applicableResults posted
• Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin LymphomaCompletedNCT01132807Phase 2Results posted
• Bioavailability Study of Colcrys® Crushed and Sprinkled on ApplesauceCompletedNCT01130051Phase 1Results posted
• Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based TherapyCompletedNCT01129206Phase 2Results posted
• Lapatinib in Combination With VinorelbineCompletedNCT01128543Phase 2Results posted
• Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder CancerTerminatedNCT01126749Phase 1/2Results posted
• Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung CancerCompletedNCT01126736Phase 1/2Results posted
• Bioavailability Study of Colcrys® in Apple JuiceCompletedNCT01123395Phase 1Results posted
• Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin LymphomaCompletedNCT01118026Phase 2Results posted
• TPI 287 in Patients With Recurrent Glioblastoma MultiformeTerminatedNCT01113463Phase 2Results posted
• An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.CompletedNCT01112982Phase 4Results posted
• Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung CancerCompletedNCT01109524Phase 2Results posted
• Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial CancerCompletedNCT01108055Phase 2Results posted
• Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV MelanomaCompletedNCT01107665Phase 2Results posted
• Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone SurgeryCompletedNCT01106898Phase 2Results posted
• QT Interval Prolongation Study of Eribulin Mesylate (E7389) in Patients With Advanced Solid TumorsCompletedNCT01106248Phase 1Results posted
• Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung CancerCompletedNCT01104155Phase 2Results posted
• A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II)CompletedNCT01100931Phase 1/2Results posted
• First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube CancerCompletedNCT01097746Phase 2Results posted
• Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed EpendymomaCompletedNCT01096368Phase 3Results posted
• Trial of Vinflunine Plus Capecitabine in Advanced Breast CancerCompletedNCT01095003Phase 3Results posted
• A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel RegimenCompletedNCT01094288Phase 1Results posted
• Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast CancerCompletedNCT01091168Phase 3Results posted
• Hedgehog Inhibitors for Metastatic Adenocarcinoma of the PancreasCompletedNCT01088815Phase 2Results posted
• Study of TAK-700 in Combination With Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate CancerCompletedNCT01084655Phase 1/2Results posted
• Healthy and Renal Impairment Study of Colcrys (Colchicine, USP)CompletedNCT01084278Phase 4Results posted
• Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube CancerActive, not recruitingNCT01081262Phase 3Results posted
• Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate CancerCompletedNCT01076335Phase 2Results posted
• Ixabepilone + Carboplatin Metastatic Breast CancerCompletedNCT01075100Phase 2Results posted
• Phase II Study of Tesetaxel in Metastatic MelanomaCompletedNCT01064713Phase 2Results posted
• A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and NeckCompletedNCT01059643Phase 2Results posted
• Study Evaluating Chemotherapy in Combination With Inotuzumab Ozogamicin In Subjects With Non-Hodgkin's LymphomaCompletedNCT01055496Phase 1Results posted
• Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable AngiosarcomaTerminatedNCT01055028Phase 2Results posted
• Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal TumorsStatus unknownNCT01042522Phase 2Results posted
• Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial CancerTerminatedNCT01041027Phase 2Results posted
• A Pharmacokinetic Study of Colchicine With an Oral ContraceptiveCompletedNCT01040845Phase 1Results posted
• Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast CancerCompletedNCT01036087Phase 2Results posted
• BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell CarcinomaCompletedNCT01034631Phase 1/2Results posted
• Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT01031446Phase 1/2Results posted
• Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin LymphomaCompletedNCT01026220Phase 3Results posted
• Bioequivalence Study of Colchicine TabletsCompletedNCT01021020Phase 1Results posted
• Pharmacokinetic and Exploratory Electrocardiogram (ECG) StudyCompletedNCT01018420Phase 1Results posted
• Pharmacokinetic Study of an Acute Gout RegimenCompletedNCT01017042Phase 1Results posted
• Pharmacokinetic Study With Colchicine in Healthy VolunteersCompletedNCT01017003Phase 1Results posted
• Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic MelanomaCompletedNCT01014351Phase 2Results posted
• Lapatinib in Combination With VinorelbineCompletedNCT01013740Phase 2Results posted
• Study of Pazopanib and Ixabepilone in Patients With Solid TumorsTerminatedNCT01012362Phase 1Results posted
• Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung CancerCompletedNCT01011075Phase 2Results posted
• Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast CancerTerminatedNCT01009983Phase 2Results posted
• Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic MelanomaTerminatedNCT01009515Phase 2Results posted
• Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial CancerCompletedNCT01005329Phase 2Results posted
• Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid TumorTerminatedNCT01001221Phase 1/2Results posted
• Relative Bioavailability of Colcrys™ 0.6 mg Tablets in Healthy Young and Elderly Volunteers Under Fasted ConditionsCompletedNCT01001052Phase 1Results posted
• Evaluating the Pharmacokinetics and Tolerance of Co-administration of Oral Multiple Dose of Ketoconazole and an IV (Bolus) Infusion of Eribulin in Patients With Advanced Solid TumorsCompletedNCT01000376Phase 1Results posted
• Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate CancerTerminatedNCT00996502Phase 1/2Results posted
• Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB)CompletedNCT00996333Phase 2Results posted
• Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial CancerTerminatedNCT00995488Phase 2Results posted
• A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic OriginCompletedNCT00993044Phase 1Results posted
• Drug-Drug Interaction Study of Colchicine and ClarithromycinCompletedNCT00984061Phase 1Results posted
• A Drug-Food Interaction Study Between Colchicine and Grapefruit JuiceCompletedNCT00984009Phase 1Results posted
• Drug-Drug Interaction Study Between Colchicine and CyclosporineCompletedNCT00983931Phase 1Results posted
• Drug-Drug Interaction Study of Colchicine and TheophyllineCompletedNCT00983905Phase 1Results posted
• Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric CancerCompletedNCT00983801Phase 2Results posted
• Drug-Drug Interaction Between Colchicine and RitonavirCompletedNCT00983515Phase 1Results posted
• Drug-Drug Interaction Study Between Colchicine and Diltiazem ERCompletedNCT00983372Phase 1Results posted
• Drug-Drug Interaction Study of Colchicine and AzithromycinCompletedNCT00983294Phase 1Results posted
• Drug-Drug Interaction Between Colchicine and Verapamil ERCompletedNCT00983242Phase 1Results posted
• Drug-Drug Interaction Study Between Colchicine and KetoconazoleCompletedNCT00983216Phase 1Results posted
• Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical HysterectomyCompletedNCT00980954Phase 3Results posted
• Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver CancerCompletedNCT00980460Phase 3Results posted
• Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial CancerActive, not recruitingNCT00977574Phase 2Results posted
• Treatment of Older Adults With Acute Lymphoblastic LeukemiaCompletedNCT00973752Phase 2Results posted
• Paclitaxel and CBT-1(Registered Trademark) to Treat Solid TumorsCompletedNCT00972205Not applicableResults posted
• Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast CancerCompletedNCT00971945Phase 2Results posted
• Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck CancerCompletedNCT00971867Phase 2Results posted
• Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal CancerCompletedNCT00971841Phase 2Results posted
• Bevacizumab, Docetaxel, and Gemcitabine Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerCompletedNCT00970684Phase 2Results posted
• Study of E7389 for Advanced or Metastatic Breast CancerCompletedNCT00965523Phase 2Results posted
• A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLCCompletedNCT00963807Phase 2Results posted
• Drug-Drug Interaction Study Between Colchicine and AtorvastatinCompletedNCT00960323Phase 1Results posted
• Drug-Food Interaction Study of Seville Orange Juice and ColchicineCompletedNCT00960193Phase 1Results posted
• Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid TumorsCompletedNCT00958724Phase 1Results posted
• Safety and Feasibility Study of Combination of State of Art Chemoimmunotherapy, Intensive Central Nervous System Prophylaxis and Scrotal Irradiation to Treat Primary Diffuse Large B-cell Lymphoma of TestisCompletedNCT00945724Phase 2Results posted
• Combination Chemotherapy With CS-1008 to Treat Ovarian CancerCompletedNCT00945191Phase 2Results posted
• Combination Chemotherapy and Surgery in Treating Young Patients With Wilms TumorCompletedNCT00945009Phase 3Results posted
• Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 ExpressionCompletedNCT00944047Phase 2Results posted
• A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate CancerCompletedNCT00942578Phase 2Results posted
• Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionCompletedNCT00938470Phase 2Results posted
• A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian CancerCompletedNCT00937560Phase 2Results posted
• High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell TumorsCompletedNCT00936936Phase 2Results posted
• Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown PrimaryCompletedNCT00936702Phase 2Results posted
• Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast CaTerminatedNCT00934895Phase 1/2Results posted
• A Study to Evaluate Corrected QT Interval and Drug-Drug Interaction of Trastuzumab on Carboplatin in the Presence of Docetaxel in Patients With HER2-Positive Metastatic or Locally Advanced Inoperable CancerCompletedNCT00927589Phase 1Results posted
• Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast CancerCompletedNCT00924352Phase 1/2Results posted
• Ixabepilone to Treat Cervical CancerTerminatedNCT00924066Phase 2Results posted
• Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney CancerCompletedNCT00923130Phase 2Results posted
• A Study to Determine the Metabolism and Elimination of Carbon-14 Labeled Eribulin Acetate (14C-Eribulin) in Patients With Advanced Solid TumorsCompletedNCT00908908Phase 1Results posted
• Afatinib and Vinorelbine in Tumours Known to Overexpress EGFR and/or HER2CompletedNCT00906698Phase 1Results posted
• Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) SalvageCompletedNCT00905034Phase 2Results posted
• Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)CompletedNCT00896181Phase 2Results posted

← Antimitotic Agents overview